Charting the future in prostate cancer care: A call to action


Multi-disciplinary team approach featured in public service announcement

LOS ANGELES, Sept. 9 -- This year, an estimated 230,000 men will be diagnosed with prostate cancer in the United States, and 30,000 are expected to die from the disease. Today, about two million men are battling prostate cancer, and over the next decade, about three million more will be compelled to join the war. The need for new therapies is great, and since 1993, The Prostate Cancer Foundation has played a pivotal role in supporting and funding R&D breakthroughs to defeat this disease.

The timing is becoming ever more critical. As the baby boomer men reach the target age for prostate cancer, beginning at age 50, this disease will become the cancer with the greatest increase in incidence, in addition to being the most common non-skin cancer in the U.S. In fact, over the next decade, the number of new prostate cancer cases in the U.S. is expected to increase by 50 percent to more than 300,000 new cases per year. Unfortunately, even today, prostate cancer treatment and research has lagged behind other areas, such as that of breast cancer, where there has been recent progress in integration among specialties and late-stage innovation of new therapeutics.

On September 22, 2004, the Prostate Cancer Foundation (PCF) will release its Report to the Nation on Prostate Cancer, authored by 24 leading prostate cancer experts. A distinguished panel will present the major findings of the Report and its authors' calls to action to address the urgent need to improve the management of prostate cancer and accelerate the development of better treatments and a cure. The PCF will also debut a public service announcement campaign "It's a TEAM Approach: Prostate Cancer Treatment, Education, Awareness and Management". The PSA features golf legend Arnold Palmer, a prostate cancer survivor, who encourages a multi-disciplinary team approach to this deadly disease, which affects one in six men in their lifetime.

Who: Panelists and Special Guests will include:

  • Joseph L. Bruno, NY State Senator and President of the NY State Senate

  • Peter J. Carroll, MD, Professor and Chair, Department of Urology, University of California, San Francisco and executive editor of the PCF's Report to the Nation on Prostate Cancer.

  • Leslie D. Michelson, Vice Chairman and CEO of the Prostate Cancer Foundation

  • Michael Milken, Founder and Chairman of the Prostate Cancer Foundation

  • Daniel P. Petrylak, MD, Associate Professor of Medicine at Columbia University College of Physicians & Surgeons, and Director of the Genitourinary Oncology Program, New York- Presbyterian Hospital and author of the PCF's Report to the Nation on Prostate Cancer.

  • Peter T. Scardino, MD, Chairman, Department of Urology; Florence and Theodore Baumritter/Enid Ancell Chair of Urologic Oncology, Memorial Sloan Kettering Cancer Center.

  • Joe Torre, manager of the NY Yankees and prostate cancer survivor

When: Wednesday, September 22, 2004, 11:00 am to 12 noon
(arrival & reception beginning at 10:30am)

Where: New York Academy of Sciences
2 East 63rd St. (between Madison and 5th Ave.) New York, NY 10021

How: Register with Justin Jackson ([email protected]) or Maria Ronan ([email protected]), 212-213-0006.

Web site:

Source: Eurekalert & others

Last reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
    Published on All rights reserved.